Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model
Clinical Science · 2024
DOI: 10.1042/cs20240190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Tsai-Der Chuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, CA, U.S.A. Hauptthemen laut MEDLINE: Leiomyoma, RNA, Long Noncoding, MicroRNAs, Cell Proliferation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NICHD.
Abstract (Originalsprache)
Our previous studies indicated that there is overexpression of MIAT in fibroids and MIAT is a sponge for the miR-29 family in these tumors. The objective of the present study was to determine if the knockdown of MIAT in fibroid xenografts will increase miR-29 levels and reduce the expression of genes targeted by this miRNA such as collagen and cell cycle regulatory proteins in a mouse model for fibroids. Ovariectomized CB-17 SCID/Beige mice bearing estrogen/progesterone pellets were implanted subcutaneously in the flank with equal weight of fibroid explants which had been transduced by lentivirus for either control (empty vector) or MIAT knockdown for four weeks (n=7). Knockdown of MIAT in fibroid xenografts resulted in a 30% reduction of tumor weight and a marked increase in miR-29a, -b, and -c levels in the xenografts. There was reduced cell proliferation and expression of cell cycle regulatory genes CCND1, CDK2, and E2F1 and no significant changes in apoptosis. The xenografts with MIAT knockdown expressed lower mRNA and protein levels of FN1, COL3A1, and TGF-β3, and total collagen protein. Targeting MIAT, which sponges the pro-fibrotic miR-29 family, is an effective therapy for fibroids by reducing cell proliferation and thereby, tumor growth and accumulation of ECM, which is a hallmark of these benign gynecologic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, CA, U.S.A.
- The Lundquist Institute for Biomedical Innovation, Torrance, CA, U.S.A.
- Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, U.S.A.
ORCID-Profile: Omid Khorram
Förderung
- NICHD NIH HHS
- NICHD
Zitieren
APA
Chuang, T. D., Ton, N., Manrique, N., Rysling, S., & Khorram, O. (2024). Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model. Clinical Science. https://doi.org/10.1042/cs20240190
Vancouver
Chuang TD, Ton N, Manrique N, Rysling S, Khorram O. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model. Clinical Science. 2024. doi:10.1042/cs20240190
BibTeX
@article{Chuang2024,
author = {Chuang, Tsai-Der and Ton, Nhu and Manrique, Nathaly and Rysling, Shawn and Khorram, Omid},
title = {Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model},
journal = {Clinical Science},
year = {2024},
doi = {10.1042/cs20240190}
}
EUVIMED